Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptotic cell death in a new human chronic myelogenous leukemia cell line, KT-1, by interferon-α

Blood

Volumn 91, Issue 2, 1998, Pages 641-648

  Yanagisawa, Kohsuke ^a   Yamauchi, Hayato ^b   Kaneko, Masahiko ^b   Kohno, Hidehisa ^b   Hasegawa, Hitoshi ^b   Fujita, Shigeru ^b  

^a EHIME UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; MYELOPEROXIDASE;

APOPTOSIS; ARTICLE; BLAST CELL CRISIS; CANCER INHIBITION; CELL DEATH; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHRONIC MYELOID LEUKEMIA; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0031983334     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.2.641.641_641_648     Document Type: Article

References (38)

1. Rowley J: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and giemsa staining. Nature 243:290, 1973
2. Kurzrock R, Gutterman JU, Talpaz M: The molecular genetics of Philadelphia chromosome positive leukemia. N Engl J Med 319:990, 1988
3. Shtivelman E, Lifshitz B, Gale RP, Canaani E: Fused transcripts of abl and bcr genes in chronic myelogenous leukemia. Nature 315:550, 1985
4. Ben-Neriah Y, Daley GQ, Mes-Masson AM, Witte ON, Baltimore D: The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene. Science 233:212, 1986
5. Konopa JB, Watanabe SM, Whitte ON: An alternation of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035, 1984
6. Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ: Inhibition of apoptosis by bcr-abl in chronic myeloid leukemia. Blood 83:2038, 1994
7. Cortez D, Kadlec L, Pendergast AM: Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis. Mol Cell Biol 15:5531, 1995
8. McGahon A, Bissonette R, Schmitt M, Cotter KM, Green DR, Cotter TG: BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 83:1179, 1994
9. Wetzler M, Kurzrock R, Lowe DG, Kantarjian H, Gutterman JU, Talpaz M: Alternation in bone marrow adherent layer growth factor expression: A novel mechanism of chronic myelogenous leukemia progression. Blood 78:2400, 1991
10. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210 bcr-abl gene of the Philadelphia chromosome. Science 247:824, 1990
11. Talpaz M, Kantarjian H, McCredie K, Trujillo JM, Keating MJ, Gutterman JU: Hematological remission and cytogenetic improvement induced by recombinant interferon alpha in chronic myelogenous leukemia. N Engl J Med 314:1065, 1986
12. Kantarjian H, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
13. Ozer H, George SL, Schiffer CA, Rao K, Rao PN, Wurster-Hill DH, Arther DD, Powell B, Gottlieb A, Peterson BA, Rai K, Testa JR, LeBeau M, Tantravahi R, Bloomfield CD: Prolonged subcutaneous administration of recombinant ab2 interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase myelogenous leukemia: Effect on remission duration and survival: Cancer and Leukemia Group B study 8583. Blood 82:2975, 1993
14. Tura S, Bacearani M, Zuffa E, Russo D, Fanin R, Zaccaria A, Fiacchini M, Italian Cooperative Study Group on Chronic Myeloid Leukemia: Interferon alfa-2a as compared with conventional chemotherapy for treatment of chronic myeloid leukemia. N Engl J Med 330:820, l994
15. Talpaz M, Kantarjian H, Kurzrock R, Trujillo JM, Gutterman JU: Interferon alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med 114:532, 1991
16. Talpaz M, Estrov Z. Kantarjian H, Ku S, Foteh A, Kurzrock R: Persistence of dormant leukemic progenitors during interferon-induced remission in chronic myelogenous leukemia: Analysis by polymerase chain reaction of individual colonies. J Clin Invest 94:1383, 1994
17. Schulze E, Krahl R, Thalmeier K, Heibig W: Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: Comparison with cytogenetics and PCR from uncultured cells. Exp Hematol 23:1649, 1995
18. Davey FR, Erber WN, Gatter KC, Mason DY: Immunophenotyping of acute myeloid leukemia by immuno alkaline phosphatase (APAAP) labeling with a panel of antibodies. Am J Hematol 26:157, 1987
19. Seabright M: A rapid banding technique for human chromosomes. Lancet 2:971, 1971
20. Sagloi G, Guerrasio A, Rosso C, Zaccaria A, Tassinari A, Serra A, Rege-Cambrin G, Mazza U, Gavosto F: New type of BCR/ABL junction in Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 76:1819, 1990
21. Zaccaria A, Martinelli G, Buzzi M, Testoni N, Farabegoli P, Zuffa E, Zamagni MD, Russo D, Baccarani M, Ambrosetti A, Guerrasio A, Saglio G, Tura S: The type of bcr/abl junction dose not predict the survival of patients with Ph 1 -positive chronic myeloid leukemia. Br J Haematol 84:265, 1993
22. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493, 1992
23. Borden EC. Fall LA: Interferons: Biochemical, cell growth inhibitory and immunological effects. Prog Hematol 350:16, 1981
24. Gresser I: On the varied biological effects of interferon. Cell Immunol 34:406, 1977
25. Kurzrock R, Talpaz M, Kantarjian H, Walters R, Saks S, Trujillo JM, Gutterman JU: Therapy of chronic myelogenous leukemia with interferon-γ. Blood 70:943, 1987
26. Russo D, Zuffa E, Fanin R: Treatment of chronic myeloid leukemia by gamma interferon. Blut 59:15, 1989
27. Opalka B, Wandl UB, Becher R, Kloke O, Nagel-Hiemke M, Moritz T, Beer U, Seeber S, Niederle N: Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γ. Blood 78:2188, 1991
28. Andrews DF, Singer JW, Collins SJ: Effect of recombinant α-interferon on the expression of the bcr-abl fusion gene in human chronic myelogenous leukemia cell lines. Cancer Res 47:6629, 1987
29. bcr/abl protein during hemininduced erythroid differentiation of K-562 cells. Exp Hematol 19:161, 1991
30. Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R: Subcellular localization of bcr, abl, and bcr-abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 92:1925, 1993
31. Selleri C, Sato T, Vecchio LD, Luciano L, Barrett AJ, Rotoli B, Young NS, Maciejewski JP: Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-α in chronic myelogenous leukemia. Blood 89:957, 1997
32. Klimpl GR, Fleischmann WR Jr, Klimpl KD: Gamma interferon (IFN-gamma) and IFN-alpha/beta suppress murine myeloid colony formation (CFU-C): Magnitude of suppression is dependent upon level of colony-stimulating factor (CSF). J Immunol 129:76, 1982
33. Velazquez L, Fellows M, Stark GR, Pellegrini S: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313, 1992
34. Muller M, Briscoe J, Laxton C, Gushuin D, Ziemiecki A, Silvennoinen O, Harpur AG, Barbieri G, Witthuhn BA, Schindler C: The protein tyrosine kinase JAK1 complements defects in interferon α/β and -γ signal transduction. Nature 366:129, 1933
35. Watling D, Gushuin D, Muller M, Slivennoinen O, Witthuhn BA, Quellw FW, Rogers NG, Schindler C, Stark GR, Ihle JN; Complementation of a mutant cell line defective in the interferon-γ signal transduction pathway by the protein tyrasine kinase Jak2. Nature 366:166, 1993
36. Schindler G, Fu X-Y, Improta T, Aebersold R, Parnell JE Jr: Proteins of transcription factor ISGF-3: One gene encodes the 91 and 84 KDAISGF-3 proteins that are activated by Interferon-α. Proc Natl Acad Sci USA 89:7836, 1992
37. Fu X-Y, Schindler C, Improta T, Aebersold R, Darnell JE Jr: The proteins of ISGF-3: The interferon α-indttced transcriptional activator, define a gene family involved in signal transduction. Proc Natl Acad Sci USA 89:7840,1992
38. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr: Activation of transcription by IFN-γ. Tyrosine phosphorylation of a 91kD DNA binding protein. Science 259:1808, 1992